Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Intravesical bacille Calmette-Guérin (BCG) therapy for bladder cancer is associated with eradication of uropathogens in patients not taking antibiotics, according to a new…
Ajay Verma, MD, PhD, VP, Neurodegeneration & Translational Neurology, Biogen Idec, suggests that we carry a biologic blueprint for death that may include “grim reaper” mechanisms. Filmed at FutureMed,…
Randy Scott, PhD, Executive Chairman, Genomic Health, talks about advances in genome-based testing and understanding of cancer. Filmed at FutureMed, in February, 2012, at Singularity University.
Amir Belson, MD, CTO, Neoguide Systems, discusses his invention of the Neoguide colonoscope. Filmed at FutureMed, in February, 2012, at Singularity University.
Dale Bredesen, MD, Professor & Founding President, Buck Institute, explains the model of Alzheimer’s Disease as a prion loop disorder, and the implications of that model for future…
Jeremy Bailenson, Director, Virtual Human Interaction Lab, Stanford University, talks about the power of virtual reality technology to effect behavioral change, especially in the challenging area of lifestyle…
Author Sonia Arrison, MA, talks about the implications of relatively inexpensive, widely available genome sequencing, which she says is not far off. Filmed at FutureMed, in February, 2012, at Singularity…
Jeremy Bailenson, Director, Virtual Human Interaction Lab, Stanford University, talks about the power of virtual reality technology to effect behavioral change, especially in the challenging area of lifestyle…
